UPDATE 1-U.S. FDA approves Roche's immunotherapy for bladder cancer

May 18 (Reuters) - The U.S. Food and Drug Administration on

Wednesday granted accelerated approval for Roche Holding AG's

immunotherapy for the most common form of bladder

cancer, marking the...

Read more